This issue marks 10 years since the launch of The Lancet HIV. Reflecting on our inaugural Editorial from October, 2014, is a bittersweet exercise. The past decade has witnessed steady advances in HIV ...
Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital ...